Pediatric Cushing's syndrome: Clinical features, diagnosis, and treatment

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 51, Issue 8, 2007, Pages 1261-1271

  Chan, Li F ^a   Storr, Helen L ^a   Grossman, Ashley B ^a   Savage, Martin O ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adrenal tumours; Cushing's disease; Cushing's syndrome; Pediatrics

Indexed keywords

EID: 38649090726     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302007000800012     Document Type: Review

References (65)

1. Pessanha TM, Campos JM, Barros AC, Pone MV, Garrido JR, Pone SM. Iatrogenic Cushing's syndrome in a adolescent with AIDSs on Ritonavir and inhaled Fluticasone. Case report and literature review. AIDS 2007;21(4):529-32.
2. Volkl TM, Dorr HG. McCune-Albright syndrome: Clinical picture and natural history in children and adolescents. J Pediatr Endocrinol Metab 2006;199(suppl 2):551-9.
3. Ribeiro RC, Figueiredo B. Childhood adrenocortical tumours. Eur J Cancer 2004;40(8):1117-26.
4. Storr HL, Isidori AM, Monson JP, Besser GM, Grossman AB, Savage MO. Prepubertal Cushing's disease is more common in males, but there is no increase in severity at diagnosis. J Clin Endocrinol Metab 2004;89(8):3818-20.
5. Newell-Price J, Trainer P, Besser M, Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 1998;19(5):647-72.
6. Storr HL, Afshar F, Matson M, Sabin I, Davies KM, Evanson J, et al. Factors influencing cure by transsphenoidal selective adenomectomy in paediatric Cushing's disease. Eur J Endocrinol 2005;152(6):825-33.
7. Magiakou MA, Chrousos GP. Cushing's syndrome in children and adolescents: Current diagnostic and therapeutic strategies. J Endocrinol Invest 2002;25(2):181-94.
8. Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, et al. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an Effective second-line treatment. J Clin Endocrinol Metab 2003;88(1):34-7.
9. Newell-Price J, Bertagna X, Grossman AB, Nieman LK. Cushing's syndrome. Lancet 2006;367(9522):1605-17.
10. Greening JE, Storr HL, McKenzie SA, Davies KM, Martin L, Grossman AB, et al. Linear growth and body mass index in pediatric patients with Cushing's disease or simple obesity. J Endocrinol Invest 2006;29(10):885-7.
11. Weber A, Trainer PJ, Grossman AB, Afshar F, Medbak S, Perry LA, et al. Investigation, management and therapeutic outcome in 12 cases of childhood and adolescent Cushing's syndrome. Clin Endocrinol (Oxf) 1995;43(1):19-28.
12. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB, et al. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 1994;331(10):629-36.
13. Storr HL, Chan LF, Grossman AB, Savage MO. Paediatric Cushing's syndrome: Epidemiology, investigation and therapeutic advances. Trends Endocrinol Metab 2007;18(4):167-74.
14. Greening JE, Brain CE, Perry LA, Mushtaq I, Sales Marques J, Grossman AB, et al. Efficient short-term control of hypercortisolaemia by low-dose etomidate in severe paediatric Cushing's disease. Horm Res 2005;64(3):140-3.
15. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, et al. Diagnosis and complications of Cushing's syndrome: a Consensus statement. J Clin Endocrinol Metab 2003;88(12):5593-602.
16. Damiani D, Aguiar CH, Crivellaro CE, Galvão JA, Dichtchekenian V, Setian N. Pituitary macroadenoma and Cushing's disease in pediatric patients: Patient report and review of the literature. J Pediatr Endocrinol Metab 1998;11(5):665-9.
17. Stratakis CA, Schussheim DH, Freedman SM, Keil MF, Pack SD, Agarwal A et al. Pituitary macroadenoma in a 5-year-old: an Early expression of Multiple Endocrine Neoplasia type 1. J Clin Endocrinol Metab 2000;85(12):4776-80.
18. Peters CJ, Ahmed ML, Storr HL, Davies KM, Martin LJ, Allgrove J, et al. Factors influencing skeletal maturation at diagnosis of paediatric Cushing's disease. Horm Res 2007;68(5):231-5.
19. Dupuis CC, Storr HL, Perry LA, Ho JT, Ahmed L, Ong KK, et al. Abnormal puberty in paediatric Cushing's disease: Relationship with adrenal androgen, sex hormone binding globulin and gonadotrophin concentrations. Clin Endocrinol (Oxf) 2007;66(6):838-43.
20. Isidori AM, Kaltsas GA, Pozza C, Frajese V, Newell-Price J, Reznek RH, et al. The ectopic adrenocorticotropin syndrome: Clinical features, diagnosis, management, and long-term follow-up. J Clin Endocrinol Metab 2006;91(2):371-7.
21. Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing's syndrome due to ectopic corticotropin secretion: Twenty years' experience at the National Institutes of Health. J Clin Endocrinol Metab 2005;90(8):4955- 62.
22. Hannah J, Lippe B, Lai-Goldman M, Bhuta S. Oncocytic carcinoid of the kidney associated with periodic Cushing's syndrome. Cancer 1988;61(10):2136-40.
23. Amano S, Hazama F, Haebara H, Tsurusawa M, Kaito H. Ectopic ACTH-MSH producing carcinoid tumor with multiple endocrine hyperplasia in a child. Acta Pathol Jpn 1978;28(5):721-30.
24. Espinasse-Holder M, Defachelles AS, Weill J, De Keyzer Y, de Lasalle EM, Nelken B. Paraneoplastic Cushing syndrome due to adrenal neuroblastoma. Med Pediatr Oncol 2000;34(3):231-3.
25. Hsiao JC, Yang CP, Lin CJ, Chuen H. Ectopic ACTH syndrome due to clear cell sarcoma of the kidney. Child Nephrol Urol 1991;11(2):103-6.
26. Hinnie J, Gray CE, McNicol AM, Carter R, Thomson JA, White A, et al. Cushing's syndrome in a 16 year old girl due to ectopic ACTH precursor production from a pancreatic tumour. Clin Endocrinol (Oxf) 2000;53(4):539-40.
27. Thomas RJ, Sen S, Zachariah N, Mammen KE, Raghupathy P, Seshadri MS, et al. Wilms' tumor presenting as Cushing's syndrome. Pediatr Surg Int 1998;13(4):293-4.
28. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, Lafferty AR, et al. An inherited P53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A 2001;98(16):9330-5.
29. Michalkiewicz E, Sandrini R, Figueiredo B, Miranda EC, Caran E, Oliveira-Filho AG, et al. Clinical and outcome characteristics of children with adrenocortical tumors: a Report from the International Pediatric Adrenocortical Tumor Registry. J Clin Oncol 2004;22(5):838-45.
30. Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 1984; 8(5):335-44.
31. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation, and endocrine overactivity. Medicine (Baltimore) 1985;64(4):270-83.
32. Storr HL, Mitchell H, Swords FM, Main KM, Hindmarsh PC, Betts PR, et al. Clinical features, diagnosis, treatment and molecular studies in paediatric Cushing's syndrome due to primary nodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 2004;61(5):553-9.
33. Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, et al. Cyclical Cushing syndrome presenting in infancy: An early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 2004;89(7):3173-82.
34. Stratakis CA, Kirschner LS. Clinical and genetic analysis of primary bilateral adrenal diseases (micro- and macronodular disease) leading to Cushing syndrome. Horm Metab Res 1998;30(6-7):456-63.
35. Sarlis NJ, Chrousos GP, Doppman JL, Carney JA, Stratakis CA. Primary pigmented nodular adrenocortical disease: Reevaluation of a patient with Carney complex 27 years after unilateral adrenalectomy. J Clin Endocrinol Metab 1997;82(4):1274-8.
36. Kirschner LS, Sandrini F, Monbo J, Lin JP, Carney JA, Stratakis CA. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex. Hum Mol Genet 2000;9(20):3037-46.
37. Groussin L, Jullian E, Perlemoine K, Louvel A, Leheup B, Luton JP, et al. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease. J Clin Endocrinol Metab 2002;87(9):4324-9.
38. Groussin L, Horvath A, Jullian E, Boikos S, Rene-Corail F, Lefebvre H, et al. A PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease in 12 kindreds. J Clin Endocrinol Metab 2006;91(5):1943-9.
39. Bourdeau I. Clinical and molecular genetic studies of bilateral adrenal hyperplasias. Endocr Res 2004;30(4):575-83.
40. Lieberman SA, Eccleshall TR, Feldman D. ACTH-independent massive bilateral adrenal disease (AIMBAD): a Subtype of Cushing's syndrome with major diagnostic and therapeutic implications. Eur J Endocrinol 1994;131(1):67-73.
41. Lumbroso S, Paris F, Sultan C. McCune-Albright syndrome: Molecular genetics. J Pediatr Endocrinol Metab 2002;15(suppl 3):875-82.
42. Kirk JM, Brain CE, Carson DJ, Hyde JC, Grant DB. Cushing's syndrome caused by nodular adrenal hyperplasia in children with McCune-Albright syndrome. J Pediatr 1999;134(6):789-92.
43. Boston BA, Mandel S, LaFranchi S, Bliziotes M. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 1994; 79(3):890-3.
44. Yaneva M, Mosnier-Pudar H, Dugue M, Grabar S, Fulla Y, Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 2004;89(7):3345-51.
45. Peters CJ, Storr HL, Grossman AB, Savage MO. The role of corticotrophin-releasing hormone in the diagnosis of Cushing's syndrome. Eur J Endocrinol 2006;155(suppl 1):S93-8.
46. Dias R, Storr HL, Perry LA, Isidori AM, Grossman AB, Savage MO. The discriminatory value of the low-dose dexamethasone suppression test in the investigation of paediatric Cushing's syndrome. Horm Res 2006;65(3):159- 62.
47. Doppman JL. Problems in endocrinologic imaging. Endocrinol Metab Clin North Am 1997;26(4):973-91.
48. Batista D, Gennari M, Riar J, Chang R, Keil MF, Oldfield EH, et al. An assessment of petrosal sinus sampling for localization of pituitary microadenomas in children with Cushing disease. J Clin Endocrinol Metab 2006;91(1):221-4.
49. Joshi SM, Hewitt RJ, Storr HL, Rezajooi K, Ellamushi H, Grossman AB, et al. Cushing's disease in children and adolescents: 20 Years of experience in a single neurosurgical center. Neurosurgery 2005;57(2):281-5.
50. Massoud AF, Powell M, Williams RA, Hindmarsh PC, Brook CG. Transsphenoidal surgery for pituitary tumours. Arch Dis Child 1997;76(5):398-404.
51. Trainer PJ, Lawrie HS, Verhelst J, Howlett TA, Lowe DG, Grossman AB, et al. Transsphenoidal resection in Cushing's disease: Undetectable serum cortisol as the definition of successful treatment. Clin Endocrinol (Oxf) 1993;38(1):73-8.
52. Storr HL, Plowman PN, Carroll PV, Francois I, Krassas GE, Afshar F, et al. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing's disease: an Effective second-line treatment. J Clin Endocrinol Metab 2003;88(1):34-7.
53. Chan LF, Storr HL, Plowman PN, Perry LA, Besser GM, Grossman AB, et al. Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur J Endocrinol 2007;156(4):477-82.
54. Leinung MC, Kane LA, Scheithauer BW, Carpenter PC, Laws ER Jr, Zimmerman D. Long term follow-up of transsphenoidal surgery for the treatment of Cushing's disease in childhood. J Clin Endocrinol Metab 1995;80(8):2475-9.
55. McArthur RG, Hayles AB, Salassa RM. Childhood Cushing disease: Results of bilateral adrenalectomy. J Pediatr 1979;95(2):214-9.
56. Magiakou MA, Mastorakos G, Chrousos GP. Final stature in patients with endogenous Cushing's syndrome. J Clin Endocrinol Metab 1994;79(4):1082-5.
57. Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, et al. Linear growth and final height after treatment for Cushing's disease in childhood. J Clin Endocrinol Metab 2000;85(9):3262-5.
58. Davies JH, Storr HL, Davies K, Monson JP, Besser GM, Afshar F, et al. Final adult height and body mass index after cure of paediatric Cushing's disease. Clin Endocrinol (Oxf) 2005;62(4):466-72.
59. Carroll PV, Monson JP, Grossman AB, Besser GM, Plowman PN, Afshar F, et al. Successful treatment of childhood-onset Cushing's disease is associated with persistent reduction in growth hormone secretion. Clin Endocrinol (Oxf) 2004;60(2):169-74.
60. Leong GM, Abad V, Charmandari E, Reynolds JC, Hill S, Chrousos GP, et al. Effects of child- and adolescent-onset endogenous Cushing syndrome on bone mass, body composition, and growth: a 7-Year prospective study into young adulthood. J Bone Miner.Res 2007;22(1):110-8.
61. Scommegna S, Greening JP, Storr HL, Davies KM, Shaw NJ, Monson JP, et al. Bone mineral density at diagnosis and following successful treatment of pediatric Cushing's disease. J Endocrinol Invest 2005;28(3):231-5.
62. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP. The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 1997;82(3):912-9.
63. Sonino N, Fava GA. Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 2001;15(5):361-73.
64. Forget H, Lacroix A, Cohen H. Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 2002;27(3):367-83.
65. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, et al. Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 2002;87(5):1949- 54.